hVIVO
Business Services · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
10-12 Alie St Fl 2, London, Greater Lond...Website
www.hvivo.comRevenue
$71.4 MillionStock Symbol
HVOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About hVIVO
Founded in 1989 and headquartered in London, UK, hVIVO is a specialty biopharma company with clinical testing capabilities, that is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is hVIVO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once hVIVO has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
hVIVO, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at hVIVO
Check out if hVIVO is spiking on competitors!
Click to see if hVIVO had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when hVIVO launches new products
Check if hVIVO has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on hVIVO recently announced quarterly report
Recommended Actions
Find VP level buyers at hVIVO
Find 3 more new buyers
Compare Similar Companies to hVIVO
Compare insights from companies similar to hVIVO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
hVIVO
$71.4M
201-500
Public
-
1989
N/A
Company Profile Activity
Activity Insights
hVIVO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
hVIVO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about hVIVO.
hVIVO Tech Stack
A closer look at the technologies used by hVIVO
Most Recent Scoops
Person-Based
Stephen Pinkerton May 13, 2026, Annual General Meeting, all resolutions were passed by shareholders.
Governance
Person-Based
Clinical Operations, Contracts
Person-Based
Earnings, Finance
Person-Based
Person-Based
hVIVO News & Media
hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Therapeutics - Small Cap Snapshot
hVIVO PLC (AIM:HVO) has signed its largest-ever human challenge trial contract, testing a whooping cough vaccine for US biotech ILiAD Biotechnologies. The trial will involve more than 500 volunteers and is expected to generate the majority of its revenue across 2026 and 2027. Rift Helium PLC (AIM:RIFT) made a strong debut on AIM, with shares opening 10% above the 10p issue price after raising £8.1 million. The Tanzania-focused explorer is targeting a 19 billion cubichVIVO plc (OPORF) Q4 2025 Sales/Trading Call Transcript
hVIVO plc (OPORF) Q4 2025 Sales/Trading Call January 29, 2026 1:00 PM ESTCompany ParticipantsYamin Khan - CEO & DirectorStephen Pinkerton - CFO &...hVIVO CEO and CFO increase stakes, signalling confidence - Vox Markets
hVIVO(AIM: HVO), the human challenge trial specialist, has reported substantial director share purchases by CEO Yamin ‘Mo’ Khan and CFO Stephen Pinkerton, suggesting management believes the current share price undervalues the business.CEO & CFO Share Purchase | Company Announcement - Investegate
Investegate announcements from CEO & CFO Share Purchase
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding hVIVO
Sign Up For FreeTo access detailed company insights
Founded in 1989 and headquartered in London, UK, hVIVO is a specialty biopharma company with clinical testing capabilities, that is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases.... Read More
